NCT04735003 Transcatheter Interventions for Tricuspid Insufficiency in Italy
| NCT ID | NCT04735003 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Marianna Adamo |
| Condition | Tricuspid Valve Insufficiency |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-01-30 |
| Primary Completion | 2026-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2021-01-30 with a primary completion date of 2026-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational, multi-center, retrospective and prospective study collecting data about patients undergoing transcatheter tricuspid valve interventions in a real world clinical environment. The aim is to report clinical characteristics, procedural results and short- and long-term outcomes of patients undergoing transcatheter tricuspid valve interventions in Italian centres.
Eligibility Criteria
Inclusion Criteria: 1. Patients undergoing transcatheter treatment of tricuspid regurgitation (native valve -with or without previous surgical valve repair - or degenerated bioprosthesis) 2. Patients who are willing and capable of providing informed consent, and participating in all follow-ups associated with this clinical investigation. Exclusion Criteria: 1. Valve anatomy unsuitable for transcatheter tricuspid valve interventions. 2. Subjects who are unable or not willing to complete follow-up visits and examination for the duration of the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04735003 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Tricuspid Valve Insufficiency. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04735003 currently recruiting?
Yes, NCT04735003 is actively recruiting participants. Contact the research team at mariannaadamo@hotmail.com for enrollment information.
Where is the NCT04735003 trial being conducted?
This trial is being conducted at Brescia, Italy.
Who is sponsoring the NCT04735003 clinical trial?
NCT04735003 is sponsored by Marianna Adamo. The trial plans to enroll 200 participants.